Since we did not find any overexpression of Bcl-2 family members in peripheral blood of RA/SLE patient samples and our BH3 mimetic results showed more effects in healthy controls, we have not yet sufficient data to support the use of any of the tested BH3 mimetic drugs in the treatment of autoimmunity. The gene discussed is BCL2; the disease is rheumatoid arthritis.